Han Wang
Beijing, 100029, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 18 publications
Fangchinoline restores TFEB-driven lysosomal biogenesis and blocks H1N1 infection.
Journal: Acta pharmacologica Sinica
Published: September 24, 2025
AEBP1 as a promising therapeutic target for skeletal muscle insulin resistance in type 2 diabetes mellitus: Convergent evidence from Mendelian randomization and functional validation.
Journal: Metabolism: clinical and experimental
Published: January 18, 2025
Effects of natural products on macrophage immunometabolism: A new frontier in the treatment of metabolic diseases.
Journal: Pharmacological research
Published: October 31, 2024
The effects of Gegen Qinlian decoction and its main constituents on glucolipid metabolic disorders in diabetes: an overview of systematic reviews and meta-analysis.
Journal: Systematic reviews
Published: October 20, 2024
Targeting gut microbiota as a therapeutic target in T2DM: A review of multi-target interactions of probiotics, prebiotics, postbiotics, and synbiotics with the intestinal barrier.
Journal: Pharmacological research
Published: August 31, 2024
Inhibition of endoplasmic reticulum stress and excessive autophagy by Jiedu Tongluo Tiaogan Formula via a CaMKKβ/AMPK pathway contributes to protect pancreatic β-cells.
Journal: Journal of ethnopharmacology
Published: April 02, 2024
Double-blinded, randomized clinical trial of Gegen Qinlian decoction pinpoints Faecalibacterium as key gut bacteria in alleviating hyperglycemia.
Journal: Precision clinical medicine
Published: December 07, 2023
Mitochondrial regulation of diabetic endothelial dysfunction: Pathophysiological links.
Journal: The international journal of biochemistry & cell biology
Published: December 07, 2023
Crosstalk among podocytes, glomerular endothelial cells and mesangial cells in diabetic kidney disease: an updated review.
Journal: Cell communication and signaling : CCS
Published: August 20, 2023
Multiomics Analyses With Stool-Type Stratification in Patient Cohorts and Blautia Identification as a Potential Bacterial Modulator in Type 2 Diabetes Mellitus.
Journal: Diabetes
Published: June 08, 2023
Stem cell-derived exosomal MicroRNAs: Potential therapies in diabetic kidney disease.
Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
Published: April 13, 2023
The mechanism of berberine alleviating metabolic disorder based on gut microbiome.
Journal: Frontiers in cellular and infection microbiology
Published: January 14, 2022
Last Updated: 09/26/2026